Literature DB >> 8089125

Differing structural requirements for GTPase-activating protein responsiveness and NADPH oxidase activation by Rac.

X Xu1, D C Barry, J Settleman, M A Schwartz, G M Bokoch.   

Abstract

The Rac GTP-binding proteins regulate the actin cytoskeleton and the superoxide-forming NADPH oxidase of phagocytic leukocytes. These functions of Rac are determined by the GTP/GDP state of the protein, which can be modulated by GTPase-activating proteins (GAPs). The interaction of Ras with both downstream signaling targets and GAPs is mediated via an "effector" domain (amino acids 30-40). We demonstrate that the effector domain of Rac2 is required for both NADPH oxidase activation and actin assembly, but that mutations in this region do not decrease the responsiveness of Rac to GAPs. In contrast, mutations of residues 12 (Gly-->Val) or 61 (Gln-->Leu) inhibit both intrinsic- and GAP-stimulated GTP hydrolysis by Rac2. A double mutation in which both the effector domain and Q61L were modified restored NADPH oxidase activation and membrane ruffling, while the equivalent effector domain and G12V double mutation did not. The Rac2 Q61L mutant had an increased "affinity" for NADPH oxidase activation and for GAP binding as compared to the wild type or G12V proteins. These experiments suggest that Rac contains at least two "effector" interaction sites, and that changes in binding interactions at one of these sites may influence the function of the other.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089125

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function.

Authors:  Xiaoyu Li; Xia Bu; Binfeng Lu; Hava Avraham; Richard A Flavell; Bing Lim
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 2.  Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines.

Authors:  Peter Penzes; Michael E Cahill
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-12

3.  Functions and functional domains of the GTPase Cdc42p.

Authors:  K G Kozminski; A J Chen; A A Rodal; D G Drubin
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

4.  Induction of protein-protein interactions in live cells using light.

Authors:  Masayuki Yazawa; Amir M Sadaghiani; Brian Hsueh; Ricardo E Dolmetsch
Journal:  Nat Biotechnol       Date:  2009-10-04       Impact factor: 54.908

5.  Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation.

Authors:  R Foster; K Q Hu; Y Lu; K M Nolan; J Thissen; J Settleman
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  Rho family GTPases and neuronal growth cone remodelling: relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid.

Authors:  R Kozma; S Sarner; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

7.  Multiple p21ras effector pathways regulate nuclear factor of activated T cells.

Authors:  E Genot; S Cleverley; S Henning; D Cantrell
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

8.  Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family.

Authors:  T H Chuang; X Xu; V Kaartinen; N Heisterkamp; J Groffen; G M Bokoch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

9.  Mechanism of Cdc42-induced actin polymerization in neutrophil extracts.

Authors:  S H Zigmond; M Joyce; C Yang; K Brown; M Huang; M Pring
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

10.  Rac GTPase interacts specifically with phosphatidylinositol 3-kinase.

Authors:  G M Bokoch; C J Vlahos; Y Wang; U G Knaus; A E Traynor-Kaplan
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.